Vaishali Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

VAISHALI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+8.4%1-day move

₹6.09

prior close

₹6.19

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-3.7-3.2-3.1-3.1+8.4+7.6+23.2+26.4+46.5+36.8+23.2+15.8+19.5+30.2

Up moveDown movePending

AI summary

Vaishali Pharma Limited has submitted a compliance certificate under SEBI Regulation 74(5) for Q4 FY2026 (January to March 2026). The company's Registrar and Transfer Agent, Bigshare Services Pvt. Ltd., confirmed that the regulation is not applicable because 100% of the company's shares are already held in dematerialized (demat) form. No shareholder requested rematerialization during the quarter. This is a routine regulatory filing confirming proper maintenance of shareholder records in demat format.

Likely market impact

No direct impact on shareholders or stock price. This is a standard compliance confirmation indicating all shares are properly dematerialized with no pending shareholder requests for physical share certificates.